A retrospective study comparing the clinical outcomes including both Ischaemic and bleeding events, in patients with acute Myocardial Infarction undergoing percutaneous coronary intervention
Latest Information Update: 16 Mar 2021
Price :
$35 *
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Aspirin
- Indications Cardiovascular disorders; Myocardial infarction; Stroke
- Focus Adverse reactions; Therapeutic Use
- 16 Mar 2021 New trial record
- 12 Mar 2021 Results published in the Heart